Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 646.87

+0.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: cl who wrote (121)	7/9/1997 6:51:00 AM
From: harkenman	of 3557

The key is getting approval is that a drug is safe and EFFECTIVE!. Myotrophin may meet the first criteria but fails the second based on the review panel's evaluation. FDA will not approve drug due to political pressure or DATELINE/National Enquirer type interviews/newsmagazine. The facts will get approvals. A tIND has been approved for Myo. Let them prove effectiviness there and then they will get approval which IMO will never happen. Rilutek is the only drug proven to date to work for ALS. Post your interview on the CEPH board. You may have better luck. By the way there was some insider buying activity reported by VICKERS reported in June 1997 for CEPH.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next